6533b86efe1ef96bd12cbc0f

RESEARCH PRODUCT

Are Anticoagulants and Antiplatelet Agents Important in Thoracic Surgery?

R. FerrandisJuan V. Llau

subject

Thrombotic riskAspirinmedicine.medical_specialtyCardiothoracic surgerybusiness.industryAntithromboticmedicineAnticoagulant AgentIn patientIntensive care medicinebusinessOptimal managementmedicine.drug

description

The management of antithrombotic drugs (antiplatelet and anticoagulant agents) is a common challenging issue in patients undergoing thoracic surgery. The procedure can require the temporary interruption of these drugs because of their associated haemorrhagic risk, therefore assuming a thrombotic risk also. The assessment of the balance between both risks gives us their optimal management.

yearjournalcountryeditionlanguage
2020-01-01
https://doi.org/10.1007/978-3-030-28528-9_15